Drug · DIN 02087294
SERZONE-5HT2
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 28, 2003; first marketed July 16, 1997.
- Drug Identification Number (DIN)
- 02087294
- Company (DIN owner)
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Nefazodone N06AX06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NEFAZODONE HYDROCHLORIDE | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 7, 2000: NOC 1355Supplement to a New Drug Submission (SNDS) · Change in product name from serzone
- April 27, 1994: NOC 5444New Drug Submission (NDS)
Other DINs named SERZONE-5HT2
- DIN 02087375 · Cancelled Post Market
- DIN 02087383 · Cancelled Post Market
- DIN 02087391 · Cancelled Post Market